Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis.
D000328:Adult; D001407:Bacillus; D002506:Cephalexin / Q000627:therapeutic use; D002509:Cephaloridine / Q000627:therapeutic use; D002511:Cephalosporins / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D002512:Cephalothin / Q000627:therapeutic use; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004361:Drug Tolerance; D004697:Endocarditis, Bacterial / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006556:Heroin Dependence / Q000150:complications; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013440:Sulfides / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D013830:Thiadiazoles / Q000627:therapeutic use
D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D002509:Cephaloridine; D002506:Cephalexin; D002512:Cephalothin